Anti-hsp60 antibody responses based on Helicobacter pylori in patients with multiple sclerosis: (ir)Relevance to disease pathogenesis

Journal of Neuroimmunology

Volumn 298, Issue , 2016, Pages 19-23

  Efthymiou, Georgios ^a,b   Dardiotis, Efthymios ^b   Liaskos, Christos ^a,b   Marou, Emmanouela ^a,b   Tsimourtou, Vana ^b   Scheper, Thomas ^c   Meyer, Wolfgang ^c   Daponte, Alexandros ^b   Sakkas, Lazaros I ^b   Hadjigeorgiou, Georgios ^b   Bogdanos, Dimitrios P ^a,b  

^a INFORMATION TECHNOLOGIES INSTITUTE   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

^c Institute of Experimental Immunology   (Germany)

Author keywords

Antibody; Autoimmunity; Heat shock protein; Molecular mimicry

Indexed keywords

HEAT SHOCK PROTEIN 60 ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; CHAPERONIN 60;

ADULT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BACTERIUM IDENTIFICATION; BLOOD SAMPLING; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; MULTIPLE SCLEROSIS; NONHUMAN; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; AGE; BLOOD; COMPLICATION; HELICOBACTER INFECTION; IMMUNOLOGY; MIDDLE AGED; PATHOGENICITY;

ADULT; AGE FACTORS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; CHAPERONIN 60; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 84976869137     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2016.06.009     Document Type: Article

References (35)

1. Axsen, W.S., Styer, C.M., Solnick, J.V., Inhibition of heat shock protein expression by helicobacter pylori. Microb. Pathog. 47 (2009), 231–236.
2. Bogdanos, D.P., Baum, H., Gunsar, F., Arioli, D., Polymeros, D., Ma, Y., Burroughs, A.K., Vergani, D., Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity. Scand. J. Gastroenterol. 39 (2004), 981–987.
3. Chiba, S., Yokota, S., Yonekura, K., Tanaka, S., Furuyama, H., Kubota, H., Fujii, N., Matsumoto, H., Autoantibodies against HSP70 family proteins were detected in the cerebrospinal fluid from patients with multiple sclerosis. J. Neurol. Sci. 241 (2006), 39–43.
4. Daponte, A., Pournaras, S., Deligeoroglou, E., Skentou, H., Messinis, I.E., Serum interleukin-1β, interleukin-8 and anti-heat shock 60 Chlamydia trachomatis antibodies as markers of ectopic pregnancy. J. Reprod. Immunol. 93 (2012), 102–108.
5. Deretzi, G., Gavalas, E., Boziki, M., Tsiptsios, D., Polyzos, S.A., Venizelos, I., Zavos, C., Koutlas, E., Tsiptsios, I., Katsinelos, P., Kountouras, J., Impact of Helicobacter pylori on Multiple Sclerosis-Related clinically Isolated Syndrome. 2015 (Acta Neurol Scand).
6. Gonzalez-Lopez, M.A., Velazquez-Guadarrama, N., Romero-Espejel, M.E., Olivares-Trejo JDE, J., Helicobacter pylori secretes the chaperonin GroEL (HSP60), which binds iron. FEBS Lett. 587 (2013), 1823–1828.
7. Grigoriadis, n., Hadjigeorgiou, G.M., Virus-mediated autoimmunity in multiple sclerosis. J. Autoimmune. Dis., 3, 2006, 1.
8. Gruber, R., Lederer, S., Bechtel, U., Lob, S., Riethmuller, G., Feucht, H.E., Increased antibody titers against mycobacterial heat-shock protein 65 in patients with vasculitis and arteriosclerosis. Int. Arch. Allergy Immunol. 110 (1996), 95–98.
9. Hadjigeorgiou, G.M., Doxani, C., Miligkos, M., Ziakas, P., Bakalos, G., Papadimitriou, D., Mprotsis, T., Grigoriadis, N., Zintzaras, E., A network meta-analysis of randomized controlled trials for comparing the effectiveness and safety profile of treatments with marketing authorization for relapsing multiple sclerosis. J. Clin. Pharm. Ther. 38 (2013), 433–439.
10. Henderson, B., Intergrating the cell stress response: a new view of molecular chaperones as immunological and physiological homeostatic regulators. Cell Biochem. Funct. 28 (2010), 1–14.
11. Horvath, L., Czirjak, L., Fekete, B., Jakab, L., Prohaszka, Z., Cervenak, L., Romics, L., Singh, M., Daha, M.R., Fust, G., Levels of antibodies against C1q and 60 kDa family of heat shock proteins in the sera of patients with various autoimmune diseases. Immunol. Lett. 75 (2001), 103–109.
12. Jarjour, W.N., Jeffries, B.D., Davis, J.S.T., Welch, W.J., Mimura, T., Winfield, J.B., Autoantibodies to human stress proteins. a survey of various rheumatic and other inflammatory diseases. Arthritis Rheum. 34 (1991), 1133–1138.
13. Katz Sand, I., Classification, diagnosis, and differential diagnosis of multiple sclerosis. Curr. Opin. Neurol. 28 (2015), 193–205.
14. Kountouras, J., Gavalas, E., Deretzi, G., Boziki, M., Zavos, C., Chatzopoulos, D., Katsinelos, P., Giartza-Taxidou, E., Grigoriadis, N., Venizelos, I., Helicobacter pylori with or without its neutrophil-activating protein may be the common denominator associated with multiple sclerosis and neuromyelitis optica. Mult. Scler. 16 (2010), 376–377 (author reply 378-9).
15. Koutsoumpas, A., Mytilinaiou, M., Polymeros, D., Dalekos, G.N., Bogdanos, D.P., Anti-Helicobacter pylori antibody responses specific for VacA do not trigger primary biliary cirrhosis-specific antimitochondrial antibodies. Eur. J. Gastroenterol. Hepatol., 21, 2009, 1220.
16. Krzysiek-Maczka, G., Targosz, A., Ptak-Belowska, A., Korbut, E., Szczyrk, U., Strzalka, M., Brzozowski, T., Molecular alterations in fibroblasts exposed to Helicobacter pylori: a missing link in bacterial inflammation progressing into gastric carcinogenesis?. J. Physiol. Pharmacol. 64 (2013), 77–87.
17. Kusters, J.G., Van Vliet, A.H., Kuipers, E.J., Pathogenesis of Hwelicobacter pylori infection. Clin. Microbiol. Rev. 19 (2006), 449–490.
18. Li, W., Minohara, M., Su, J.J., Matsuoka, T., Osoegawa, M., Ishizu, T., Kira, J., Helicobacter pylori infection is a potential protective factor against conventional multiple sclerosis in the Japanese population. J. Neuroimmunol. 184 (2007), 227–231.
19. Long, Y., Gao, C., Qiu, W., Hu, X., Shu, Y., Peng, F., Lu, Z., Helicobacter pylori infection in neuromyelitis optica and multiple sclerosis. Neuroimmunomodulation 20 (2013), 107–112.
20. Milo, R., Miller, A., Revised diagnostic criteria of multiple sclerosis. Autoimmun. Rev. 13 (2014), 518–524.
21. Mohebi, N., Mamarabadi, M., Moghaddasi, M., Relation of helicobacter pylori infection and multiple sclerosis in Iranian patients. Neurol. Int. 5 (2013), 31–33.
22. Ontaneda, D., Fox, R.J., Progressive multiple sclerosis. Curr. Opin. Neurol. 28 (2015), 237–243.
23. Ontaneda, D., Fox, R.J., Chataway, J., Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives. Lancet Neurol. 14 (2015), 208–223.
24. Panchapakesan, J., Daglis, M., Gatenby, P., Antibodies to 65 kDa and 70 kDa heat shock proteins in rheumatoid arthritis and systemic lupus erythematosus. Immunol. Cell Biol. 70:Pt 5 (1992), 295–300.
25. Pedrini, M.J., Seewann, A., Bennett, K.A., Wood, A.J., James, I., Burton, J., Marshall, B.J., Carroll, W.M., Kermode, A.G., Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females. J. Neurol. Neurosurg. Psychiatry 86 (2015), 603–607.
26. Pezeshki, M.Z., Zarrintan, S., Zarrintan, M.H., Helicobacter pylori nanoparticles as a potential treatment of conventional multiple sclerosis. Med. Hypotheses, 70, 2008, 1223.
27. Salvetti, M., Buttinelli, C., Ristori, G., Carbonari, M., Cherchi, M., Fiorelli, M., Grasso, M.G., Toma, L., Pozzilli, C., T-lymphocyte reactivity to the recombinant mycobacterial 65- and 70-kDa heat shock proteins in multiple sclerosis. J. Autoimmun. 5 (1992), 691–702.
28. Scotti, C., Mignosi, P., Filipazzi, P., Lazze, M.C., Savio, M., Cappelletti, D., Pasquetto, M.V., Solcia, E., Vannini, V., Sommi, P., Molecular alterations in fibroblasts exposed to Helicobacter pylori broth culture filtrate: a potential trigger of autoimmunity?. Helicobacter 15 (2010), 76–77.
29. Smyk, D.S., Koutsoumpas, A.L., Mytilinaiou, M.G., Rigopoulou, E.I., Sakkas, L.I., Bogdanos, D.P., Helicobacter pylori and autoimmune disease: cause or bystander. World J. Gastroenterol. 20 (2014), 613–629.
30. Targosz, A., Pierzchalski, P., Krawiec, A., Szczyrk, U., Brzozowski, T., Konturek, S.J., Pawlik, W.W., Helicobacter pylori inhibits expression of heat shock protein 70 (HSP70) in human epithelial cell line. Importance of Cag A protein. J. Physiol. Pharmacol. 57 (2006), 265–278.
31. Tishler, M., Shoenfeld, Y., Anti-heat-shock protein antibodies in rheumatic and autoimmune diseases. Semin. Arthritis Rheum. 26 (1996), 558–563.
32. Udvarnoki, K., Cervenak, L., Uray, K., Hudecz, F., Kacskovics, I., Spallek, R., Singh, M., Fust, G., Prohaszka, Z., Antibodies against C-reactive protein cross-react with 60-kilodalton heat shock proteins. Clin. Vaccine Immunol. 14 (2007), 335–341.
33. Van Eden, W., Van Der Zee, R., Prakken, B., Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat. Rev. Immunol. 5 (2005), 318–330.
34. Vanet, A., Labigne, A., Evidence for specific secretion rather than autolysis in the release of some Helicobacter pylori proteins. Infect. Immun. 66 (1998), 1023–1027.
35. Wender, M., Prevalence of Helicobacter pylori infection among patients with multiple sclerosis. Neurol. Neurochir. Pol. 37 (2003), 45–48.